Mediators of Inflammation / 2010 / Article / Tab 1

Clinical Study

Pro/Anti-Inflammatory Cytokine Imbalance in Postischemic Left Ventricular Remodeling

Table 1

Baseline characteristics of patients.

Remodeling patients (n=20)Not remodeling patients (n=20)P

Age, y64±763±9NS
Male : female13/712/8NS
Risk factors, n (%)
 Familiarity12 (60%)10 (50%)NS
 Smoke4 (20%)6 (30%)NS
 Hypertension2 (10%)3(15%)NS
 Diabetes00NS
 Hypercolesterolemia4 (20%)4 (20%)NS
Anterior and/or lateral infarction14 (70%)13 (65%)NS
Q wave at admission12 (60%)10 (50%)NS
Time to reperfusion (hour)5  ±45±3NS
Troponin peak4  ±  23.5±1NS
Treatment at discharge
 Antiaggregants20 (100%)20 (100%)NS
 B-blockers12 (60%)10 (50%)NS
 ACE-inhibitors20 (100%)20 (100%)NS
 Diuretics16 (80%)15 (75%)NS
 Nitrates12 (60%)12 (60%)NS
 Statins20 (100%)20 (100%)NS
Baseline echocardiographic features
 LVEDV (mL)93  ±  797  ±  6NS
 LVESV (mL)53  ±  756  ±  7NS
 EF (%)44  ±  442±  5NS

LVEDV: left ventricular end-diastolic volume; LVESV: left ventricular end-systolic volume; EF: ejection fraction. NS: not significant; **P<.01.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.